A Randomized Phase II Study of Durvalumab (MEDI4736) and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Durvalumab (Primary) ; Tremelimumab (Primary) ; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms MEDISARC
- 22 Mar 2018 Status changed from not yet recruiting to recruiting.
- 19 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Jan 2018.
- 05 Dec 2017 Planned initiation date changed from 1 Nov 2017 to 1 Dec 2017.